Who makes Timolol gel forming solution, 0.5%?

Timolol gel forming solution, 0.5% is developed by Alcon Research.

What development phase is Timolol gel forming solution, 0.5% in?

Timolol gel forming solution, 0.5% is FDA-approved (marketed).

Last reviewed 2026-05-13 · How we verify

Timolol gel forming solution, 0.5%

Alcon Research · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Timolol gel forming solution, 0.5%
Sponsor	Alcon Research
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Comparative Study of the Pharmacokinetic Profiles of Timolol Maleate Ophthalmic Gel With Timolol Maleate Gel (PHASE1)
Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH) (PHASE2)
Absorption and Safety of Topical Timolol to Treat Chronic Wounds
Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol (PHASE1)
Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension (PHASE3)
Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension (PHASE4)
Timolol Option for Ulcerated Hemangiomas (TOUCH Trial) (PHASE2)
Adjunctive Study of AL-37807 Ophthalmic Suspension (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Timolol gel forming solution, 0.5% CI brief — competitive landscape report
Timolol gel forming solution, 0.5% updates RSS · CI watch RSS
Alcon Research portfolio CI